Rompelberg C[au] - Search Results

Year	Number of Results
1993	1
1995	1
1996	5
2000	1
2002	2
2003	1
2004	2
2005	3
2006	2
2007	3
2008	1
2010	3
2011	7
2012	2
2016	1
2023	0

1

State of the art in benefit-risk analysis: food and nutrition.

Tijhuis MJ, de Jong N, Pohjola MV, Gunnlaugsdóttir H, Hendriksen M, Hoekstra J, Holm F, Kalogeras N, Leino O, van Leeuwen FX, Luteijn JM, Magnússon SH, Odekerken G, Rompelberg C, Tuomisto JT, Ueland Ø, White BC, Verhagen H. Tijhuis MJ, et al. Among authors: rompelberg c. Food Chem Toxicol. 2012 Jan;50(1):5-25. doi: 10.1016/j.fct.2011.06.010. Epub 2011 Jun 12. Food Chem Toxicol. 2012. PMID: 21679741 Review.

2

Functional foods and dietary supplements: products at the interface between pharma and nutrition.

Eussen SR, Verhagen H, Klungel OH, Garssen J, van Loveren H, van Kranen HJ, Rompelberg CJ. Eussen SR, et al. Among authors: rompelberg cj. Eur J Pharmacol. 2011 Sep;668 Suppl 1:S2-9. doi: 10.1016/j.ejphar.2011.07.008. Epub 2011 Jul 27. Eur J Pharmacol. 2011. PMID: 21816140 Review.

3

Costs and health effects of adding functional foods containing phytosterols/-stanols to statin therapy in the prevention of cardiovascular disease.

Eussen SR, Feenstra TL, Toxopeus IB, Hoekstra J, Klungel OH, Verhagen H, van Kranen HJ, Rompelberg CJ. Eussen SR, et al. Among authors: rompelberg cj. Eur J Pharmacol. 2011 Sep;668 Suppl 1:S91-100. doi: 10.1016/j.ejphar.2011.05.081. Epub 2011 Jul 27. Eur J Pharmacol. 2011. PMID: 21816151 Review.

4

[Folic acid fortification: prevention as well as promotion of cancer].

Kloosterman J, de Jong N, Rompelberg CJ, van Kranen HJ, Kampman E, Ocké MC. Kloosterman J, et al. Among authors: rompelberg cj. Ned Tijdschr Geneeskd. 2006 Jul 1;150(26):1443-8. Ned Tijdschr Geneeskd. 2006. PMID: 16875264 Review. Dutch.

5

Effect of eugenol on the genotoxicity of established mutagens in the liver.

Rompelberg CJ, Evertz SJ, Bruijntjes-Rozier GC, van den Heuvel PD, Verhagen H. Rompelberg CJ, et al. Food Chem Toxicol. 1996 Jan;34(1):33-42. doi: 10.1016/0278-6915(95)00091-7. Food Chem Toxicol. 1996. PMID: 8603795

6

Effects of the use of phytosterol/-stanol-enriched margarines on adherence to statin therapy.

Eussen SR, de Jong N, Rompelberg CJ, Garssen J, Verschuren WM, Klungel OH. Eussen SR, et al. Among authors: rompelberg cj. Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1225-32. doi: 10.1002/pds.2042. Epub 2010 Oct 4. Pharmacoepidemiol Drug Saf. 2010. PMID: 20922706

7

Antimutagenicity of eugenol in the rodent bone marrow micronucleus test.

Rompelberg CJ, Stenhuis WH, de Vogel N, van Osenbruggen WA, Schouten A, Verhagen H. Rompelberg CJ, et al. Mutat Res. 1995 Feb;346(2):69-75. doi: 10.1016/0165-7992(95)90053-5. Mutat Res. 1995. PMID: 7885402

8

Integrated risk-benefit analyses: method development with folic acid as example.

Hoekstra J, Verkaik-Kloosterman J, Rompelberg C, van Kranen H, Zeilmaker M, Verhagen H, de Jong N. Hoekstra J, et al. Among authors: rompelberg c. Food Chem Toxicol. 2008 Mar;46(3):893-909. doi: 10.1016/j.fct.2007.10.015. Epub 2007 Oct 25. Food Chem Toxicol. 2008. PMID: 18063287

9

Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food.

Versantvoort CH, Oomen AG, Van de Kamp E, Rompelberg CJ, Sips AJ. Versantvoort CH, et al. Among authors: rompelberg cj. Food Chem Toxicol. 2005 Jan;43(1):31-40. doi: 10.1016/j.fct.2004.08.007. Food Chem Toxicol. 2005. PMID: 15582193

10

Effect of short-term dietary administration of eugenol in humans.

Rompelberg CJ, Vogels JT, de Vogel N, Bruijntjes-Rozier GC, Stenhuis WH, Bogaards JJ, Verhagen H. Rompelberg CJ, et al. Hum Exp Toxicol. 1996 Feb;15(2):129-35. doi: 10.1177/096032719601500205. Hum Exp Toxicol. 1996. PMID: 8645503 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results